Concepedia

Publication | Open Access

Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma

DOIFull Paper Access

71

Citations

27

References

2015

Year

Salvia Jain, Xavier Jirau-Serrano, Kelly Zullo, Luigi Scotto, Carmine F. Palermo, Stephen A. Sastra, Kenneth P. Olive, Serge Cremers, Tiffany Thomas, Ying Wei,
Clinical Cancer Research

Abstract

Collectively, these data strongly suggest that the combination of pralatrexate and romidepsin merits clinical study in patients with TCLs.

References

YearCitations

Page 1